TG Therapeutics Granted Three New Patents for BRIUMVI in Treatment of Multiple Sclerosis
TG Therapeutics has recently been granted three new patents by the United States Patent and Trademark Office (USPTO) for their ...
© 2024 Stocks Today
Tag: TGTX
Analyst expresses optimism and raises price target for TG Therapeutics NASDAQTGTX
On February 5, 2024, Mayank Mamtani, an analyst at B. Riley Securities, expressed his optimistic view on TG Therapeutics (NASDAQ:TGTX). ...
TG Therapeutics Short Interest Declines Indicating Potential Shift in Market Sentiment
TG Therapeutics (NYSE:TGTX) has experienced a notable decline in its short interest, with the percentage of float falling by 12.86% ...
TG Therapeutics Expects Significant Growth and Exciting Developments in 2024
TG Therapeutics is anticipating significant growth in its BRIUMVI U.S. net product revenue for the year 2024. Based on preliminary ...
TG Therapeutics Announces Impressive Net Product Revenue Figures and Ambitious Goals for 2024
TG Therapeutics (TGTX) has just released its preliminary U.S. BRIUMVI net product revenue figures for the fourth quarter of 2023 ...
Barclays PLC Raises Stake in TG Therapeutics, Signaling Confidence in Future Growth
In a surprising move, Barclays PLC has announced that it raised its stake in TG Therapeutics, Inc. by 11.3% during ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Office Real Estate Investment Trusts REITs WellPositioned for ReturntoWork Trend